Home » Newsletters » BioWorld

BioWorld

July 22, 1994

View Archived Issues

GLAXO, BIOCHEM START PHASE III OF HBV DRUG

OTHER NEWS TO NOTE

APPOINTMENTS AND ADVANCEMENTS

HUMAN GENOME SCIENCES SIGNS 20 NEW PACTS WITH RESEARCH INSTITUTES

GENETICS INSTITUTE TO GET $20M FROM WYETH-AYERST

CELLCOR RAISES $5.25M TO CONTINUE CLINICAL TRIALS

U.S., U.K. BIOTECHNOLOGY ASSOCIATIONS FORGE LINKS

LARGEST U.K.-U.S. DEAL CELLTECH, MERCK PACK TO DEVELOP ASTHMA DRUG